Home » Stocks » PROF

Profound Medical Corp. (PROF)

Stock Price: $17.69 USD -0.16 (-0.90%)
Updated Oct 28, 2020 9:32 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 342.80M
Revenue (ttm) 4.22M
Net Income (ttm) -20.19M
Shares Out 19.38M
EPS (ttm) -1.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 28, 2020
Last Price $17.69
Previous Close $17.85
Change ($) -0.16
Change (%) -0.90%
Day's Open 17.82
Day's Range 17.62 - 17.82
Day's Volume 2,608
52-Week Range 11.06 - 19.04

More Stats

Market Cap 342.80M
Enterprise Value 339.00M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 19.38M
Float 16.31M
EPS (basic) n/a
EPS (diluted) -1.39
FCF / Share -1.29
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 385,858
Short Ratio 4.51
Short % of Float 2.37%
Beta 1.74
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 81.24
PB Ratio 6.46
Revenue 4.22M
Operating Income -15.09M
Net Income -20.19M
Free Cash Flow -15.29M
Net Cash 3.80M
Net Cash / Share 0.20
Gross Margin 57.27%
Operating Margin -357.63%
Profit Margin -365.30%
FCF Margin -362.37%
ROA -25.58%
ROE -50.90%
ROIC -131.40%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (6)

Buy 6
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(30.81% upside)
Current: $17.69
Target: 23.14
*Average 12-month USD price target from 6 stock analysts.

Financial Performance

Financial numbers in millions CAD.

Financial Overview

Revenue Growth112.41%-46.94%--
Gross Profit3.170.821.87-
Operating Income-19.77-20.19-17.63-15.64
Net Income-20.19-20.76-18.82-16.33
Shares Outstanding11.8511.85--
Earnings Per Share-1.82-2.07-0.31-0.39
Operating Cash Flow-20.03-18.29-15.57-14.50
Capital Expenditures---0.43-0.86
Free Cash Flow-20.03-18.29-16.00-15.37
Cash & Equivalents19.2230.6911.10-
Total Debt14.2511.965.15-
Net Cash / Debt4.9718.735.96-
Book Value18.6626.6314.14-
Numbers in millions CAD, except per-share numbers.

Company Profile

Company Details

Full Name Profound Medical Corp.
Country Canada
Employees 75
CEO Arun S. Menawat

Stock Information

Ticker Symbol PROF
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: PROF


Profound Medical operates as a medical technology company develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.